Merck & Co., Inc.
MRK
$93.19
$0.630.68%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
Weiss Ratings | MRK - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Good | |||
Risk Index | Weak | |||
Risk Grade | D | |||
Reward Grade | B | |||
Rating Factors | MRK - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | Good | |||
Growth Index | Excellent | |||
Efficiency Index | Excellent | |||
Solvency Index | Excellent | |||
Total Return Index | Weak | |||
Volatility Index | Weak | |||
Beta / Standard Deviation | MRK - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 0.16 | |||
Price History | MRK - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | 1.92% | |||
30-Day Total Return | -2.60% | |||
60-Day Total Return | -9.29% | |||
90-Day Total Return | -11.70% | |||
Year to Date Total Return | -6.03% | |||
1-Year Total Return | -22.64% | |||
2-Year Total Return | -11.42% | |||
3-Year Total Return | 30.68% | |||
5-Year Total Return | 38.56% | |||
52-Week High % Change | -30.78% | |||
52-Week Low % Change | 14.99% | |||
Price | MRK - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $134.63 | |||
52-Week Low Price | $81.04 | |||
52-Week Low Price (Date) | Feb 18, 2025 | |||
52-Week High Price (Date) | Jun 25, 2024 | |||
Valuation | MRK - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 235.40B | |||
Enterprise Value | 260.04B | |||
Price/Earnings (TTM) | 13.86 | |||
Earnings Per Share (TTM) | 6.73 | |||
Earnings Per Share Growth | 4,968.12% | |||
Price/Earnings To Growth | 0.00 | |||
Price/Sales (TTM) | 3.68 | |||
Price/Book (Q) | 5.09 | |||
Enterprise Value/Revenue (TTM) | 4.05 | |||
Price | $93.19 | |||
Enterprise Value/EBITDA (TTM) | 9.40 | |||
Enterprise Value/EBIT | 11.10 | |||
Market Cap Category | Mega Cap | |||
Dividends and Shares | MRK - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 2.54B | |||
Dividend Yield | 3.35% | |||
Div. Per Share (Most Recent) | $0.81 | |||
Dividend Per Share (TTM) | $3.12 | |||
Payout Ratio (TTM) | 45.80% | |||
Dividend Per Share (Most Recent) | $0.81 | |||
Company Info | MRK - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 908 740 4000 | |||
Address | 126 East Lincoln Avenue Rahway, NJ 07065 | |||
Website | www.merck.com | |||
Country | United States | |||
Year Founded | 1891 | |||
Profitability | MRK - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | 36.49% | |||
Profit Margin | 26.67% | |||
Management Effectiveness | MRK - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | 13.08% | |||
Return on Equity | 40.79% | |||
Income Statement | MRK - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | 64.17B | |||
Total Revenue (TTM) | 64.17B | |||
Revenue Per Share | $25.29 | |||
Gross Profit (TTM) | 49.47B | |||
EBITDA (TTM) | 27.67B | |||
EBIT (TTM) | 23.42B | |||
Net Income (TTM) | 17.12B | |||
Net Income Avl. to Common (TTM) | 17.12B | |||
Total Revenue Growth (Q YOY) | 6.79% | |||
Earnings Growth (Q YOY) | 405.38% | |||
EPS Diluted (TTM) | 6.73 | |||
EPS Diluted Growth (Q YOY) | 404.83% | |||
Balance Sheet | MRK - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 13.69B | |||
Cash Per Share (Q) | $5.40 | |||
Total Current Assets (Q) | 38.78B | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | 46.37B | |||
Current Ratio (Q) | 1.365 | |||
Book Value Per Share (Q) | $18.32 | |||
Total Assets (Q) | 117.11B | |||
Total Current Liabilities (Q) | 28.42B | |||
Total Debt (Q) | 38.27B | |||
Total Liabilities (Q) | 70.73B | |||
Total Common Equity (Q) | 46.31B | |||
Cash Flow | MRK - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | -7.73B | |||
Cash from Financing (TTM) | -7.03B | |||
Net Change in Cash (TTM) | 6.41B | |||
Levered Free Cash Flow (TTM) | 16.51B | |||
Cash from Operations (TTM) | 21.47B | |||